Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds

Reynisson, 2009, Bioorg. Med. Chem., 17, 3169, 10.1016/j.bmc.2009.02.049 Kölsch, 2008, J. Cell Sci., 121, 551, 10.1242/jcs.023333 Shoemaker, 2006, Nat. Rev. Drug Dis., 6, 813, 10.1038/nrc1951 Feng, 2012, Eur. J. Med. Chem., 54, 463, 10.1016/j.ejmech.2012.05.029 Arabshahi, 2014, Med. Chem. Commun., 5, 186, 10.1039/c3md00320e Arabshahi, 2015, Med. Chem. Commun., 6, 1987, 10.1039/C5MD00245A Hung, 2014, Eur. J. Med. Chem., 86, 420, 10.1016/j.ejmech.2014.09.001 Leung, 2014, Med. Chem. Commun., 5, 99, 10.1039/C3MD00290J Reynisson, 2016, Cancer Cell Int., 16, 18, 10.1186/s12935-016-0293-6 Katritch, 2010, J. Med. Chem., 53, 1799, 10.1021/jm901647p Wang, 2015, Nat. Chem., 7, 968, 10.1038/nchem.2381 Zeng, 2010, Bioorg. Med. Chem. Lett., 20, 6282, 10.1016/j.bmcl.2010.08.088 Zhou, 2012, Oncol. Rep., 28, 225 Romagnoli, 2013, J. Med. Chem., 56, 2606, 10.1021/jm400043d eMolecules, www.emolecules.com. Mosmann, 1983, Immun. Meth., 65, 55, 10.1016/0022-1759(83)90303-4 Leach, 2003, 1. Representation and manipulation of 2D molecular structures, 1 Essen, 1997, Biochemistry, 36, 1704, 10.1021/bi962512p Berman, 2003, Nat. Struct. Biol., 10, 980, 10.1038/nsb1203-980 Berman, 2000, Nuc. Acids Res., 28, 235, 10.1093/nar/28.1.235 2000 Allinger, 1977, J. Am. Chem. Soc., 99, 8127, 10.1021/ja00467a001 Jones, 1997, J. Mol. Biol., 267, 727, 10.1006/jmbi.1996.0897 Eldridge, 1997, Comp. Aid. Mol. Design, 11, 425, 10.1023/A:1007996124545 Verdonk, 2003, Proteins, 52, 609, 10.1002/prot.10465 Korb, 2009, J. Chem. Inf. Model., 49, 84, 10.1021/ci800298z Mooij, 2005, Proteins, 61, 272, 10.1002/prot.20588 2009 Ioakimidis, 2008, QSAR Comb. Sci., 27, 445, 10.1002/qsar.200730051 Alley, 1988, Cancer Res., 48, 589 Boyd, 1995, Drug Dev. Res., 34, 91, 10.1002/ddr.430340203